Cathie Wood’s ARK ETFs have disclosed their daily trades for Monday, June 9th, 2025, with significant activity across several holdings. The trades highlight ARK’s dynamic strategy and give investors insight into the fund’s latest market moves.

Topping the list of transactions, ARK invested heavily in L3HARRIS TECHNOLOGIES INC (NYSE:LHX), buying a total of 10,744 shares split between its ARKQ and ARKX (NYSE:ARKX) ETFs, amounting to a substantial $2,624,436. This purchase indicates a growing confidence in the defense technology sector.

On the sell side, ARK reduced its position in COINBASE GLOBAL INC (NASDAQ:COIN) by offloading 7,134 shares across its ARKW and ARKF ETFs, which equated to a sale value of $1,792,560. This move comes amid continuing volatility in the cryptocurrency market, which could be impacting Coinbase’s business outlook.

Further divestments included a significant sale of UIPATH INC (NYSE:PATH) shares, with 154,516 shares sold through ARKQ, totaling $2,041,156. ARK also sold 28,569 shares of the 3D PRINTING ETF (BATS:PRNT) via its ARKX ETF, valued at $612,805, suggesting a tactical retreat from specific areas of the tech sector.

In biotechnology, ARK showed a bullish trend by purchasing 26,034 shares of VERACYTE INC (NASDAQ:VCYT) through ARKK, with a total dollar value of $714,893. This follows recent purchases of VERACYTE stock last week, indicating ARK’s sustained interest in the genomic diagnostics company.

Smaller trades included a sale of 1,896 shares of AVIDXCHANGE HOLDINGS INC (NASDAQ:AVDX) for $18,580 and a modest reduction in 3D SYSTEMS CORP (NYSE:DDD) by selling 700 shares across ARKQ and ARKX ETFs, totaling $1,211.

These transactions reflect ARK’s ongoing strategy adjustments as the fund navigates the current market landscape. Investors will be watching closely to see how these trades align with ARK’s long-term vision and the impact they may have on the performance of the ETFs.